Developer docs
API playgroundTry for free, no card

Search company profiles

CIPRA.ai

Full company profile

uuid0004kaa

Namestring
CIPRA.ai
Legal namestring
CIPRA.ai, Inc.
Websiteurl
cipra.ai
Company typeenum
Private
Founded yearint
2022
Short descriptiontext

CIPRA.ai is a San Diego-based digital health company that uses Agentic AI and digital twin technology to deliver personalized chronic disease management for hypertension and diabetes, serving patients, healthcare providers, and payers across the U.S. and India.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health platform, chronic disease management, AI patient engagement, digital twin technology, remote patient monitoring
Industry2 codes
PRIMARYHLALAJAD
AI Triage & Clinical Decision Support (CDS) Platforms
Healthcare & Life Sciences/Telehealth Platforms/Urgent Care & On-Demand Triage Telehealth Platforms
SECONDARYHLACAFAE
Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Software Publishers513210
  • Software Publishers5132
SIC code1 code
  • Services-Computer Integrated Systems Design7373
Product category
Digital Health / Chronic Care Management Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Subscription-based SaaS
TypeSubscription Recurring
Description

Annual subscription model for patients and healthcare providers accessing the CIPRA.ai chronic condition management platform. Mobile app available on iOS and Android with subscription terms governed by Terms & Conditions agreement.

cipra.ai
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Subscription-based service for chronic condition management
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing details not publicly available; service offered through B2B partnerships with healthcare systems and direct-to-consumer app subscriptions.

cipra.ai
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

CIPRA.ai operates an AI-driven digital health platform that creates personalized digital twins of patients to manage and reverse chronic conditions such as hypertension and diabetes. The platform aggregates multimodal data from wearables and health monitors, then uses Agentic AI to deliver hyper-personalized lifestyle recommendations, configurable clinical notifications, and EHR-integrated dashboards for autonomous or clinician-augmented patient engagement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Sustained patient engagement rates observed in clinical trials and pilot deployments
+5 more records
Product overview1 text field

CIPRA.ai is a digital health platform built around AI-powered digital twin technology for managing chronic conditions, primarily hypertension and diabetes. The core platform combines Multimodal Data Fusion, Personal/Population Digital Twin Modeling, Agentic AI Patient Engagement, and a Clinical Dashboard into a unified system. Users interact through the CIPRA.ai Mobile Application (iOS/Android) which connects to wearables (Fitbit, Apple Watch, Garmin) and health monitors (Omron, iHealth). The platform supports multiple deployment models: fully autonomous patient self-management, semi-autonomous with minimal clinician oversight, or clinician-directed with health coaches. India Operations represents a localized variant with regional healthcare partnerships.

Product and service3 records
1CIPRA.ai Platform
CategoryDigital health platform (core product)
Description

AI-driven digital health platform that creates personalized digital twins to manage chronic conditions like hypertension and diabetes, integrating data from wearables and health monitors to deliver precise, proactive care recommendations. Targeted at health systems, providers, payers, and patients.

2CIPRA.ai Mobile Application
CategoryConsumer digital health application
Description

Interactive mobile app available on iOS and Android that enables individual patients to record meals via text or speech, track progress, and receive personalized weekly lifestyle recommendations for blood pressure and glucose management. Integrates with Apple Watch, Fitbit, Garmin, and Bluetooth blood-pressure/glucose monitors.

3CIPRA.ai India Operations
CategoryRegional digital health deployment
Description

Localized version of the CIPRA.ai platform serving the Indian market through partnerships with RxDx Healthcare and 2050 Healthcare, with innovation support from ARTPARK @IISc Bangalore. Supports chronic disease management for Indian patients and clinicians.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-09-23
Description

Techstars Healthcare Accelerator powered by Permanente Medicine Mid-Atlantic selected CIPRA.ai as one of 10 startups from approximately 800 applicants to participate in a three-month program providing access to Kaiser Permanente's physician network and healthcare innovation ecosystem. Demo day showcased AI-powered platforms for chronic disease management.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare provider partner supporting Techstars Healthcare Accelerator and providing physician network access. Dr. Katie Ryder (Co-Chief, Adult & Family Medicine) and Dr. Christopher Thomas (Regional Quality Advisor) serve as physician advisors to CIPRA.ai.

3UC San Diego Health
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare partner collaborating on AI-powered chronic condition management platform. Origin of six-year R&D and clinical trials through UCSD Connected Health Program founded by Sujit Dey.

cipra.ai
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare partner serving patients with chronic conditions through the CIPRA.ai platform deployment.

5RxDx Healthcare
Strategic tierCoreTypeStrategic or Co-development Partner
Description

India-based healthcare partner for personalized health services addressing chronic conditions. Dr. CMA Belliappa (Chief Medical Officer at RxDx Healthcare) serves as Clinician Advisor to CIPRA.ai.

cipra.ai
Strategic tierCoreTypeStrategic or Co-development Partner
Description

India-based healthcare partner collaborating with CIPRA.ai for chronic disease management services.

Strategic tierInnovationTypeTechnology or Integration
Description

Innovation partner working alongside CIPRA.ai on healthcare technology development.

Strategic tierInnovationTypeChannel Partner/ Reseller/ Distributor
Description

Innovation partner listed alongside Techstars and Murata in CIPRA.ai's innovation partner ecosystem.

Strategic tierInnovationTypeTechnology or Integration
Description

Innovation partner in CIPRA.ai's ecosystem for healthcare technology collaboration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Innovation partner and healthcare initiative collaborator at Indian Institute of Science. Dr. Bhaskar Rajakumar serves as Program Director - Healthcare at ARTPARK and Clinician Advisor to CIPRA.ai, leading healthcare innovation focused on One Health and climate change impact on health.

Strategic tierInnovationTypeTechnology or Integration
Description

Industry partner supporting the six years of R&D and clinical trials at UC San Diego that developed the CIPRA.ai platform.

12Teradata
Strategic tierInnovationTypeTechnology or Integration
Description

Industry partner supporting the R&D and clinical trials at UC San Diego that developed the CIPRA.ai platform.

cipra.ai
13Altman Clinical Translational Research Institute
Strategic tierInnovationTypeStrategic or Co-development Partner
Description

UC San Diego research institute that supported six years of R&D and clinical trials developing the CIPRA.ai platform.

cipra.ai
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Hello Heart is a digital therapeutic focused on hypertension management using a connected BP monitor and an AI-driven mobile app for self-insured employers and payers — closely aligned with CIPRA.ai's hypertension product.

2Better Therapeutics
TypeEmerging player
Description

Better Therapeutics develops prescription digital therapeutics for cardiometabolic conditions, overlapping with CIPRA.ai's hypertension/diabetes focus but targeting FDA-regulated prescription distribution rather than payer subscriptions.

TypeDirect peer
Description

Omada delivers digital care programs for diabetes prevention, hypertension, and other chronic conditions, sold primarily to payers and employers. It is a direct competitor to CIPRA.ai's payer/employer GTM motion.

TypeDirect peer
Description

Virta provides AI- and clinician-supported digital programs to reverse type 2 diabetes and other metabolic conditions. Its outcomes-driven chronic-disease reversal model directly overlaps with CIPRA.ai's hypertension and diabetes focus.

TypeDirect peer
Description

DarioHealth offers a chronic-condition management platform (diabetes, hypertension, musculoskeletal) combining connected devices, AI, and human coaching, sold to payers and employers — a comparable multi-condition digital therapeutics peer.

TypeDirect peer
Description

Twin Health uses an AI 'Whole Body Digital Twin' to reverse type 2 diabetes via personalized recommendations from wearable and sensor data — closely analogous to CIPRA.ai's digital-twin architecture and chronic-condition focus.

TypeDirect peer
Description

Livongo pioneered AI-driven chronic-condition management (diabetes, hypertension) with connected devices and personalized coaching. It is the most direct comparable to CIPRA.ai's digital-twin approach, though operating at vastly larger scale inside Teladoc Health.

TypeDirect peer
Description

WellDoc's BlueStar is an FDA-cleared digital therapeutic for type 2 diabetes using AI-driven coaching integrated with blood-glucose data. It is a direct peer on AI-driven diabetes management and clinical workflow integration.

TypeDirect peer
Description

Vida Health offers a virtual chronic-condition management platform combining AI with human coaches across diabetes, hypertension, and mental health. Comparable to CIPRA.ai on multi-condition chronic care and payer/employer distribution.

TypeDirect peer
Description

Lark provides an AI-driven chronic-disease prevention and management platform for health plans, with a conversational coaching model. It competes directly with CIPRA.ai on payer contracts and member engagement.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CIPRA.ai

Digital Health / Chronic Care Management Softwarecipra.ai

CIPRA.ai is a San Diego-based digital health company that uses Agentic AI and digital twin technology to deliver personalized chronic disease management for hypertension and diabetes, serving patients, healthcare providers, and payers across the U.S. and India.

CIPRA.ai firmographics

Firmographics
Name
CIPRA.ai
Legal name
CIPRA.ai, Inc.
Website
https://cipra.ai
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
CIPRA.ai is a San Diego-based digital health company that uses Agentic AI and digital twin technology to deliver personalized chronic disease management for hypertension and diabetes, serving patients, healthcare providers, and payers across the U.S. and India.
Ownership category
akta.pro rank

CIPRA.ai industry classification

Industry
Product category
Digital Health / Chronic Care Management Software
NAICS
Software Publishers (513210), Software Publishers (5132)
SIC
Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLALAJAD
AI Triage & Clinical Decision Support (CDS) Platforms
Healthcare & Life Sciences/Telehealth Platforms/Urgent Care & On-Demand Triage Telehealth Platforms
SECONDARYHLACAFAE
Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Digital health platform
  • Chronic disease management
  • AI patient engagement
  • Digital twin technology
  • Remote patient monitoring

Where CIPRA.ai is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices5 records

Markets served

CIPRA.ai business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Subscription-based SaaS: Annual subscription model for patients and healthcare providers accessing the CIPRA.ai chronic condition management platform. Mobile app available on iOS and Android with subscription terms governed by Terms & Conditions agreement.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSubscription-based service for chronic condition management

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

CIPRA.ai product offering

Product offering

Core offering

CIPRA.ai operates an AI-driven digital health platform that creates personalized digital twins of patients to manage and reverse chronic conditions such as hypertension and diabetes. The platform aggregates multimodal data from wearables and health monitors, then uses Agentic AI to deliver hyper-personalized lifestyle recommendations, configurable clinical notifications, and EHR-integrated dashboards for autonomous or clinician-augmented patient engagement.

Product overview

CIPRA.ai is a digital health platform built around AI-powered digital twin technology for managing chronic conditions, primarily hypertension and diabetes. The core platform combines Multimodal Data Fusion, Personal/Population Digital Twin Modeling, Agentic AI Patient Engagement, and a Clinical Dashboard into a unified system. Users interact through the CIPRA.ai Mobile Application (iOS/Android) which connects to wearables (Fitbit, Apple Watch, Garmin) and health monitors (Omron, iHealth). The platform supports multiple deployment models: fully autonomous patient self-management, semi-autonomous with minimal clinician oversight, or clinician-directed with health coaches. India Operations represents a localized variant with regional healthcare partnerships.

Differentiator

Problem solved

Functional benefit

Products and services

  • CIPRA.ai Platform AI-driven digital health platform that creates personalized digital twins to manage chronic conditions like hypertension and diabetes, integrating data from wearables and health monitors to deliver precise, proactive care recommendations. Targeted at health systems, providers, payers, and patients.
  • CIPRA.ai Mobile Application Interactive mobile app available on iOS and Android that enables individual patients to record meals via text or speech, track progress, and receive personalized weekly lifestyle recommendations for blood pressure and glucose management. Integrates with Apple Watch, Fitbit, Garmin, and Bluetooth blood-pressure/glucose monitors.
  • CIPRA.ai India Operations Localized version of the CIPRA.ai platform serving the Indian market through partnerships with RxDx Healthcare and 2050 Healthcare, with innovation support from ARTPARK @IISc Bangalore. Supports chronic disease management for Indian patients and clinicians.

Quantifiable outcome

  • Sustained patient engagement rates observed in clinical trials and pilot deployments
  • +5 more outcomes

Companies that use CIPRA.ai

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

CIPRA.ai technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability6 records

Feature6 records

CIPRA.ai partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered flagship, core and innovation.

  • TechstarsflagshipStrategic or Co-development Partner · 23 September 2025Techstars Healthcare Accelerator powered by Permanente Medicine Mid-Atlantic selected CIPRA.ai as one of 10 startups from approximately 800 applicants to participate in a three-month program providing access to Kaiser Permanente's physician network and healthcare innovation ecosystem. Demo day showcased AI-powered platforms for chronic disease management.
  • Kaiser Permanente Mid-AtlanticcoreStrategic or Co-development PartnerHealthcare provider partner supporting Techstars Healthcare Accelerator and providing physician network access. Dr. Katie Ryder (Co-Chief, Adult & Family Medicine) and Dr. Christopher Thomas (Regional Quality Advisor) serve as physician advisors to CIPRA.ai.
  • UC San Diego HealthcoreStrategic or Co-development PartnerHealthcare partner collaborating on AI-powered chronic condition management platform. Origin of six-year R&D and clinical trials through UCSD Connected Health Program founded by Sujit Dey.
  • Neighborhood HealthcarecoreStrategic or Co-development PartnerHealthcare partner serving patients with chronic conditions through the CIPRA.ai platform deployment.
  • RxDx HealthcarecoreStrategic or Co-development PartnerIndia-based healthcare partner for personalized health services addressing chronic conditions. Dr. CMA Belliappa (Chief Medical Officer at RxDx Healthcare) serves as Clinician Advisor to CIPRA.ai.
  • 2050 HealthcarecoreStrategic or Co-development PartnerIndia-based healthcare partner collaborating with CIPRA.ai for chronic disease management services.
  • MuratainnovationTechnology or IntegrationInnovation partner working alongside CIPRA.ai on healthcare technology development.
  • CarahsoftinnovationChannel Partner/ Reseller/ DistributorInnovation partner listed alongside Techstars and Murata in CIPRA.ai's innovation partner ecosystem.
  • ScaleHealthinnovationTechnology or IntegrationInnovation partner in CIPRA.ai's ecosystem for healthcare technology collaboration.
  • ARTPARK @ IISc BangalorecoreStrategic or Co-development PartnerInnovation partner and healthcare initiative collaborator at Indian Institute of Science. Dr. Bhaskar Rajakumar serves as Program Director - Healthcare at ARTPARK and Clinician Advisor to CIPRA.ai, leading healthcare innovation focused on One Health and climate change impact on health.
  • SamsunginnovationTechnology or IntegrationIndustry partner supporting the six years of R&D and clinical trials at UC San Diego that developed the CIPRA.ai platform.
  • TeradatainnovationTechnology or IntegrationIndustry partner supporting the R&D and clinical trials at UC San Diego that developed the CIPRA.ai platform.
  • Altman Clinical Translational Research InstituteinnovationStrategic or Co-development PartnerUC San Diego research institute that supported six years of R&D and clinical trials developing the CIPRA.ai platform.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

CIPRA.ai competitors and assessment

Company assessment

Direct peers

  • Hello Heart: Hello Heart is a digital therapeutic focused on hypertension management using a connected BP monitor and an AI-driven mobile app for self-insured employers and payers — closely aligned with CIPRA.ai's hypertension product.
  • Omada Health: Omada delivers digital care programs for diabetes prevention, hypertension, and other chronic conditions, sold primarily to payers and employers. It is a direct competitor to CIPRA.ai's payer/employer GTM motion.
  • Virta Health: Virta provides AI- and clinician-supported digital programs to reverse type 2 diabetes and other metabolic conditions. Its outcomes-driven chronic-disease reversal model directly overlaps with CIPRA.ai's hypertension and diabetes focus.
  • DarioHealth: DarioHealth offers a chronic-condition management platform (diabetes, hypertension, musculoskeletal) combining connected devices, AI, and human coaching, sold to payers and employers — a comparable multi-condition digital therapeutics peer.
  • Twin Health: Twin Health uses an AI 'Whole Body Digital Twin' to reverse type 2 diabetes via personalized recommendations from wearable and sensor data — closely analogous to CIPRA.ai's digital-twin architecture and chronic-condition focus.
  • Livongo (Teladoc Health): Livongo pioneered AI-driven chronic-condition management (diabetes, hypertension) with connected devices and personalized coaching. It is the most direct comparable to CIPRA.ai's digital-twin approach, though operating at vastly larger scale inside Teladoc Health.
  • WellDoc: WellDoc's BlueStar is an FDA-cleared digital therapeutic for type 2 diabetes using AI-driven coaching integrated with blood-glucose data. It is a direct peer on AI-driven diabetes management and clinical workflow integration.
  • Vida Health: Vida Health offers a virtual chronic-condition management platform combining AI with human coaches across diabetes, hypertension, and mental health. Comparable to CIPRA.ai on multi-condition chronic care and payer/employer distribution.
  • Lark Health: Lark provides an AI-driven chronic-disease prevention and management platform for health plans, with a conversational coaching model. It competes directly with CIPRA.ai on payer contracts and member engagement.

Emerging players

  • Better Therapeutics: Better Therapeutics develops prescription digital therapeutics for cardiometabolic conditions, overlapping with CIPRA.ai's hypertension/diabetes focus but targeting FDA-regulated prescription distribution rather than payer subscriptions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

CIPRA.ai social profiles

Digital presence

CIPRA.ai compliance and trust

Trust signal

Compliance1 record

CIPRA.ai financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CIPRA.ai leadership team

Management profile

Number of profiles

Profiles10 records

CIPRA.ai funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CIPRA.ai M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CIPRA.ai

What does CIPRA.ai do?

CIPRA.ai operates an AI-driven digital health platform that creates personalized digital twins of patients to manage and reverse chronic conditions such as hypertension and diabetes. The platform aggregates multimodal data from wearables and health monitors, then uses Agentic AI to deliver hyper-personalized lifestyle recommendations, configurable clinical notifications, and EHR-integrated dashboards for autonomous or clinician-augmented patient engagement.

Is CIPRA.ai a public or private company?

CIPRA.ai is a private company. It is classified as venture growth investor backed and is currently operating.

When was CIPRA.ai founded?

CIPRA.ai was founded in 2022. It employs 11 to 50 people.

Where is CIPRA.ai based?

CIPRA.ai is headquartered in San Diego, United States, in the North America region.

How does CIPRA.ai make money?

One revenue line is on record: subscription-based SaaS.

Who are CIPRA.ai's main competitors?

Direct peers on record are Hello Heart, Omada Health, Virta Health, DarioHealth, Twin Health, Livongo (Teladoc Health), WellDoc, Vida Health and Lark Health. Better Therapeutics is listed as an emerging player.

Does CIPRA.ai have an API?

No public API is recorded for CIPRA.ai.

What industry is CIPRA.ai in?

CIPRA.ai's product category is Digital Health / Chronic Care Management Software. Its primary akta.pro industry code is HLALAJAD, AI Triage & Clinical Decision Support (CDS) Platforms, with a secondary code of HLACAFAE, Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection). Its NAICS code is 513210 and its SIC code is 7373.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals